Sort   by:  
 Page size 
GenomicsTargeting RTN4/NoGo-Receptor reduces levels of ALS protein ataxin-2
Targeting RTN4/NoGo-Receptor reduces levels of ALS protein ataxin-2
PRJNA825077 | ENA
UnknownRTN4/NoGo-receptor binding to BAI adhesion-GPCRs regulates neuronal development.
Not available
S-EPMC8620742 | biostudies-literature
UnknownThe assembly of RAB22A/TMEM33/RTN4 initiates a secretory ER-phagy pathway.
Not available
S-EPMC12041605 | biostudies-literature
UnknownRTN4 Knockdown Dysregulates the AKT Pathway, Destabilizes the Cytoskeleton, and Enhances Paclitaxel-Induced Cytotoxicity in Cancers.
Not available
S-EPMC6094397 | biostudies-literature
UnknownTargeting RTN4/NoGo-Receptor reduces levels of ALS protein ataxin-2.
Not available
S-EPMC9664481 | biostudies-literature
TranscriptomicsTargeting RTN4/NoGo-Receptor reduces levels of ALS protein ataxin-2
Gene-based therapeutic strategies to lower ataxin-2 levels are emerging for neurodegenerative diseases amyotrophic lateral sclerosis (ALS) and spinocerebellar ataxia type 2 (SCA2). To identify additional ways of reducing ataxin-2 levels, we performed a genome-wide screen in human cells for regulator...
ORGANISM(S): Homo sapiens 
2022-10-18 | GSE200530 | GEO
UnknownThe Overexpression of RTN4 Significantly Associated With an Unfavourable Prognosis in Patients With Lower-Grade Gliomas.
Not available
S-EPMC11837034 | biostudies-literature
UnknownImpact of RTN4 gene polymorphism and its plasma level on susceptibility to nasopharyngeal carcinoma: A case-control study.
Not available
S-EPMC6882562 | biostudies-literature
UnknownNovel roles of RTN4 and CLIMP-63 in regulating mitochondrial structure, bioenergetics and apoptosis.
Not available
S-EPMC9068774 | biostudies-literature
UnknownTargeting Reticulin 4 (RTN4) Within Small Extracellular Vesicles Combats Metastasis and Reinforces Immunotherapy in Triple-Negative Breast Cancer.
Not available
S-EPMC12365394 | biostudies-literature
Sort   by:  
 Page size